艾地苯醌联合尼麦角林治疗慢性脑缺血头晕患者的疗效及对患者氧化应激的影响

Effects of Aldibenzoquinone Combined with Nierergerine on Oxidative Stress in Patients with Chronic Cerebral Ischemia Dizziness

【目的】探讨艾地苯醌联合尼麦角林治疗慢性脑缺血头晕患者的疗效及对患者氧化应激的影响。【方法】128例慢性脑缺血头晕患者随机分为观察组与对照组,对照组应用艾地苯醌治疗,观察组应用艾地苯醌联合尼麦角林治疗。比较两组患者临床疗效及治疗前后血清中炎性因子[肿瘤坏死因子a(TNF-α)、白介素-6(1L-6)、IL-23]、神经细胞因子[脑源性神经营养因子(BDNF)、神经生长因子(NGF)]、氧化应激因子[一氧化氮(NO)、超氧化物歧化酶(SOD)、丙二醛(MDA)]水平的变化。【结果】治疗后观察组患者临床疗效明显好于对照组(P<0.05)。治疗前两组患者血清中各项相关因子比较差异均无显著性(P>0.05);观察组患者TN F-α、IL-6、IL-23炎性因子水平均低于对照组(P<0.05);BDNF、NGF等神经细胞因子水平显著高于对照组(P<0.05);治疗后观察组NO、MDA水平低于对照组,SOD水平高于对照组(P<0.05)。【结论】艾地苯醌联合尼麦角林治疗慢性脑缺血头晕患者,可改善患者氧化应激因子水平,提升临床疗效,降低炎性因子水平,提高神经细胞因子含量,其疗效满意,值得应用。

[Objective]To investigate the efeet of aldibenzoquinone combined with Nimergoline on oxidative stress in patients with chronic cerebral ischemia dizziness.[Methods]A total of 128 patients with chronic cerebral ischemia dizziness were randomly divided into two groups.The control group was treated with aldibenzoquinone.while the observation group was trealed with aldibenzoquinone combined with nimergoline.The levels of inflamma-tory cytokines(TNF-a.IL-6 and IL.-23),never cytokine(BDNF and NGF)in serum and oxidative stress factors(NO,SOD and MDA)before and after treatment were compared between the two groups.[Results]There were no significant differences in all factors between the two groups before treatment(P>0.05).After treatment,the clinical efficacy of the observation group was significantly better than that of the control group(P<0.05).The levels of TNF-a,IL-6 and IL-23 inflammatory factors in the observation group were lower than those in the control group(P<0.05).The clinical treatment efect of the observation group was significantly better than that of the control group(P<0.05).The levels of nerve cytokines such as BDNF and NGF in the observation group after treatment were significantly higher than those in the control group(P<0.05).The levels of NO and MDA in the observation group were lower than those in the control group.while the level of SOD was higher than that in the control group(P<0.05).[Conclusion]The treatment of chronic cerebral ischemia dizziness patients with al-dibenzoquinone combined with nimergoline can improve the level of oxidative stress factor,improve the elinical treatment efect,reduce the level of inflammatory factor and improve the content of nerve cytokines.The clinical effect is satisfactory and it is worthy of appiceation.